Moderna Chairman Noubar Afeyan said the first human trial of a vaccine to prevent the coronavirus could advance to Phase II testing this spring, reported CNBC.
"It's difficult to put a specific date on things just because it's a very dynamic situation," Afeyan said, adding "we've entered Phase I trials….We'll enter hopefully Phase II trials, we expect that to happen in the spring, perhaps early summer."
Moderna partnered with the US National Institutes of Health to accelerate the development of the vaccine to prevent COVID-19, with early-stage human trials having started in the Seattle area in mid-March.
Afeyan said he expects other companies working on a vaccine, such as Johnson & Johnson, could also be successful in developing an effective one.
"We hope that everybody succeeds because the worldwide demand for these types of interventions is far in excess of what any one player can deliver," he said.
Johnson & Johnson said recently that it hoped to begin human trials of its experimental COVID-19 vaccine by September.
To read more NewsPoints articles, click here.